Skip to content

The Effects of Intravenous Fluids on Perfusion Index and Pleth Variability Index

The Evaluation of the Effects of Intravenous Fluids on Perfusion Index and Pleth Variability Index

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03048162
Enrollment
93
Registered
2017-02-09
Start date
2017-02-13
Completion date
2017-05-15
Last updated
2017-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perfusion

Brief summary

This study is aimed to assess the effects of intravenously administered three fluid types on perfusion index and pulse variability index in patients during preoperative period. Patients will be randomly divided into three groups. Baseline, 5th, 10th, 15th, 20th, 25th and 30th min non-invasive blood pressure, oxygen saturation, heart rate, room temperature, perfusion index and pulse variability index will be measured and recorded.

Detailed description

Intravenous volume replacement alter the dynamics of microcirculation. Perfusion index and pulse variability index are the recent parameters to evaluate the tissue microcirculatory condition. This study is aimed to assess the effects of intravenously administered three fluid types on perfusion index and pulse variability index in patients during preoperative period. Patients will be taken to recovery room in the operating theatre and wait for 15 minutes to balance the skin temperature of the patients to the environment. Patients will be randomly divided into three groups using closed envelope technique as Group L (received 500 ml of Ringer's lactate), Group S (500 ml of saline) and Group H (received 500 ml of 6% hydroxyethylstarch). Baseline, 5th, 10th, 15th, 20th, 25th and 30th min non-invasive blood pressure, oxygen saturation, heart rate, room temperature, perfusion index and pulse variability index will be measured and recorded.

Interventions

DRUGsodium chloride

500 ml of 0.9% isotonic sodium chloride

500 ml of 6% Hydroxyethylstarch

DRUGRinger-Lactate Infusion Solution Bag

500 ml of Ringer-Lactate Infusion Solution Bag

Sponsors

Tokat Gaziosmanpasa University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* having a fasting period of 8 hours * quit smoking for 8 hours before the procedure

Exclusion criteria

* not to participate in the study * presence of peripheral vascular disease * a history of upper extremity surgery * presence of any kind of psychiatric disease

Design outcomes

Primary

MeasureTime frameDescription
Perfusion indexsix monthsThe perfusion of the tissues

Secondary

MeasureTime frameDescription
Heart ratesix monthsHeart rate
Blood pressuresix monthsNon-invasive lood pressure
Oxygen saturationsix monthsBlood oxygen saturation using pulse oximeter
Pulse variability indexsix monthsThe intravenous fluid requirement of the tissues

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026